Original language | English |
---|---|
Pages (from-to) | 302-303 |
Number of pages | 2 |
Journal | Bone Marrow Transplantation |
Volume | 57 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2022 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Bone Marrow Transplantation, Vol. 57, No. 2, 02.2022, p. 302-303.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD
AU - Meyers, Gabrielle
AU - Hamadani, Mehdi
AU - Martens, Michael
AU - Ali, Haris
AU - Choe, Hannah
AU - Dawson, Peter
AU - Harris, Andrew C.
AU - van Hooren, Eric
AU - Klaassen, Willem
AU - Leifer, Eric
AU - MacMillan, Margaret L.
AU - van Oosterhout, Ypke
AU - Perez, Lia
AU - Pusic, Iskra
AU - Vo, Phuong
AU - Levine, John E.
N1 - Funding Information: MH: Research Support/Funding: Takeda Pharmaceutical Company; Consultancy: Incyte Corporation; ADC Therapeutics; Pharmacyclics, Omeros, Kite. Speaker’s Bureau: Sanofi Genzyme, AstraZeneca, BeiGene. HA: Consultant and speaker bureau for Incyte, BMS. Research grant from Incyte. IP: Syndax Advisory Board. EvH, WK, and YvO: are employees of Xenikos and own equity in Xenikos. JEL: Research support from Biogen, Incyte, Kamada, and Mesoblast; consulting for Bluebird, Incyte, Jazz, Mesoblast, Omeros, Symbio, Talaris, and X4 Pharmaceuticals; GVHD biomarkers patent and royalties from Viracor. Funding Information: The authors wish to acknowledge the support provided by Xenikos and Grant Numbers U10HL069294 and U24HL138660 to the Blood and Marrow Transplant Clinical Trials Network from the National Heart, Lung and Blood Institute and the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
PY - 2022/2
Y1 - 2022/2
UR - http://www.scopus.com/inward/record.url?scp=85119658579&partnerID=8YFLogxK
U2 - 10.1038/s41409-021-01529-x
DO - 10.1038/s41409-021-01529-x
M3 - Letter
C2 - 34815518
AN - SCOPUS:85119658579
SN - 0268-3369
VL - 57
SP - 302
EP - 303
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 2
ER -